Australia markets closed

Sage Therapeutics Inc (SG7.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
10.76-0.24 (-2.23%)
As of 11:00AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-503,144
-541,489
-532,784
-457,892
606,073
-
Depreciation & amortisation
1,406
1,393
1,122
4,182
2,630
-
Stock-based compensation
67,027
73,367
61,602
104,629
95,994
-
Change in working capital
14,817
-67,384
5,671
-18,506
-39,729
-
Accounts payable
-5,784
-8,495
8,433
6,689
-11,511
-
Other working capital
-425,063
-541,138
-460,973
-378,554
663,935
-
Net cash provided by operating activities
-424,735
-540,585
-460,036
-378,182
664,280
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-553
-937
-372
-345
-
Purchases of investments
-499,398
-594,670
-881,037
-1,990,151
-458,720
-
Sales/maturities of investments
887,208
1,038,136
1,207,407
988,075
901,749
-
Net cash used for investing activities
387,482
442,913
325,433
-1,002,448
442,684
-
Cash flows from financing activities
Common stock issued
-
-
0
0
417,500
561,277
Other financing activities
-2,503
-903
-43
-1,385
-
-2,503
Net cash used provided by (used for) financing activities
4,912
6,027
3,070
13,334
426,762
-
Net change in cash
-32,341
-91,645
-131,533
-1,367,296
1,533,726
-
Cash at beginning of period
207,826
163,969
295,502
1,662,798
129,072
-
Cash at end of period
175,485
72,324
163,969
295,502
1,662,798
-
Free cash flow
Operating cash flow
-424,735
-540,585
-460,036
-378,182
664,280
-
Capital expenditure
-
-553
-937
-372
-345
-
Free cash flow
-425,063
-541,138
-460,973
-378,554
663,935
-